Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Liver Neoplasms 1Disease 1Colorectal Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Dexamethasone 2vistusertib 1ricolinostat 1pomalidomide 1irinotecan sucrosofate 1idelalisib 1daratumumab 1bermekimab 1atezolizumab 1alovudine 1TKM-080301 1TIC10 compound 1S-Adenosylmethionine 1Prostatectomy 1Pluvicto 1MicroRNAs 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Ipilimumab 1Ga(III)-DOTATOC 1Fluorouracil 1Cyclophosphamide 1Blood Specimen Collection 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Disease × TKM-080301 × Clear all
NCT01437007 2018-08-03

TKM 080301 for Primary or Secondary Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
1 enrolled
BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Disease, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡